AIMS Albuminuria has been proven to be associated with cardiovascular (CV) events in specific patient populations, but also in the general population. This study aimed to investigate whether the efficacy of blood pressure-lowering agents in preventing CV events depends on baseline urinary albumin excretion (UAE) and, if so, whether this holds true for blood pressure-lowering agents in general, or is limited to agents that interfere in the renin-angiotensin system. METHODS Data were used from a community-based cohort study and pharmacy dispensing records. Included were subjects with hypertension (systolic blood pressure >= 140 and/or diastolic blood pressure >= 90 mmHg), no cardiovascular disease history, and no previous use of blood pressur...
BACKGROUND: The association between renal dysfunction and risk of cardiovascular (CV) events and...
Micro- or macroalbuminuria is associated with increased cardiovascular risk factors among patients w...
Background. As many subjects with a cardiovascular (CV) risk factor are undiagnosed, guidelines to p...
WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT * Albuminuria has been proven to be associated with cardiov...
BACKGROUND: Increased urine albumin excretion (UAE) is a well known predictor of cardiovascular ...
Aims Microalbuminuria (30-300 mg 24 h(-1)) is recognized to be independently associated with renal a...
Microalbuminuria has been shown to be a strong predictor of cardiovascular morbidity and mortality i...
Urinary albumin excretion is a predictor for cardiovascular mortality and morbidity. We investigated...
Baseline albuminuria predicts the efficacy of blood pressure-lowering drugs in preventing cardiovasc...
Albuminuria has been recognized as a risk marker for both chronic kidney disease and cardiovascular ...
Albuminuria, not only a cardiovascular/renal risk marker, but also a target for treatment? Albuminur...
Aims The long-term cardioprotective effect of angiotensin receptor blockers (ARBs) is associated wit...
Aims The long-term cardioprotective effect of angiotensin receptor blockers (ARBs) is associated wit...
background Renal function and albuminuria predict cardiovascular disease (CVD) in general population...
BACKGROUND: The association between renal dysfunction and risk of cardiovascular (CV) events and...
Micro- or macroalbuminuria is associated with increased cardiovascular risk factors among patients w...
Background. As many subjects with a cardiovascular (CV) risk factor are undiagnosed, guidelines to p...
WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT * Albuminuria has been proven to be associated with cardiov...
BACKGROUND: Increased urine albumin excretion (UAE) is a well known predictor of cardiovascular ...
Aims Microalbuminuria (30-300 mg 24 h(-1)) is recognized to be independently associated with renal a...
Microalbuminuria has been shown to be a strong predictor of cardiovascular morbidity and mortality i...
Urinary albumin excretion is a predictor for cardiovascular mortality and morbidity. We investigated...
Baseline albuminuria predicts the efficacy of blood pressure-lowering drugs in preventing cardiovasc...
Albuminuria has been recognized as a risk marker for both chronic kidney disease and cardiovascular ...
Albuminuria, not only a cardiovascular/renal risk marker, but also a target for treatment? Albuminur...
Aims The long-term cardioprotective effect of angiotensin receptor blockers (ARBs) is associated wit...
Aims The long-term cardioprotective effect of angiotensin receptor blockers (ARBs) is associated wit...
background Renal function and albuminuria predict cardiovascular disease (CVD) in general population...
BACKGROUND: The association between renal dysfunction and risk of cardiovascular (CV) events and...
Micro- or macroalbuminuria is associated with increased cardiovascular risk factors among patients w...
Background. As many subjects with a cardiovascular (CV) risk factor are undiagnosed, guidelines to p...